Publications

Search or filter publications

Search publications Search

Filter by type:

Filter by publication type

• Book
• Book chapter
• Conference paper
• Journal article
• Other
• Patent
• Poster
• Report
• Scholarly edition
• Software
• Thesis dissertation
• Working paper

Filter by year:

Filter from 202520242023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993199219911990198919881987198619851984198319821981198019791978197719761975197419731972 to Filter to 202520242023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993199219911990198919881987198619851984198319821981198019791978197719761975197419731972

---

Search results

• Journal article
  Howard SC, Donnelly CA, Kabatereine NB, Ratard RC, Brooker Set al., 2002,

  Spatial and intensity-dependent variations in associations between multiple species helminth infections

  , ACTA TROPICA, Vol: 83, Pages: 141-149, ISSN: 0001-706X
  • Author Web Link
  • Cite
  • Citations: 24
• Journal article
  Glatzel M, Rogivue C, Ghani A, Streffer JR, Amsler L, Aguzzi Aet al., 2002,

  Incidence of Creutzfeldt-Jakob disease in Switzerland

  , LANCET, Vol: 360, Pages: 139-141, ISSN: 0140-6736
  • Author Web Link
  • Cite
  • Citations: 72
• Journal article
  Stover J, Walker N, Garnett GP, Salomon JA, Stanecki KA, Ghys PD, Grassly NC, Anderson RM, Schwartländer Bet al., 2002,

  Can we reverse the HIV/AIDS pandemic with an expanded response?

  , LANCET, Vol: 360, Pages: 73-77, ISSN: 0140-6736
  • Author Web Link
  • Cite
  • Citations: 119
• Journal article
  Donnelly CA, 2002,

  BSE in France: epidemiological analysis and predictions

  , COMPTES RENDUS BIOLOGIES, Vol: 325, Pages: 793-806, ISSN: 1631-0691
  • Author Web Link
  • Cite
  • Citations: 14
• Journal article
  Garnett GP, Bartley L, Grassly NC, Anderson RMet al., 2002,

  Antiretroviral therapy to treat and prevent HIV/AIDS in resource-poor settings

  , NATURE MEDICINE, Vol: 8, Pages: 651-654, ISSN: 1078-8956
  • Author Web Link
  • Cite
  • Citations: 26
• Journal article
  Ghani AC, Ferguson NM, Fraser C, Donnelly CA, Danner S, Reiss P, Lange J, Goudsmit J, Anderson RM, De Wolf Fet al., 2002,

  Viral replication under combination antiretroviral therapy: A comparison of four different regimens

  , JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, Vol: 30, Pages: 167-176, ISSN: 1525-4135
  • Author Web Link
  • Cite
  • Citations: 12
• Journal article
  Gregson S, Nyamukapa CA, Garnett GP, Mason PR, Zhuwau T, Caraël M, Chandiwana SK, Anderson RMet al., 2002,

  Sexual mixing patterns and sex-differentials in teenage exposure to HIV infection in rural Zimbabwe

  , LANCET, Vol: 359, Pages: 1896-1903, ISSN: 0140-6736
  • Author Web Link
  • Cite
  • Citations: 407
• Journal article
  Ferguson NM, Anderson RM, 2002,

  Predicting evolutionary change in the influenza A virus

  , NATURE MEDICINE, Vol: 8, Pages: 562-563, ISSN: 1078-8956
  • Author Web Link
  • Cite
  • Citations: 19
• Journal article
  Trotter CL, Edmunds WJ, 2002,

  Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales.

  , BMJ, Vol: 324

  OBJECTIVES: To assess the cost effectiveness of a meningococcal serogroup C conjugate vaccination campaign in 0-17 year olds. DESIGN: Cost effectiveness analysis from the perspective of the healthcare provider. SETTING: England and Wales. MAIN OUTCOME MEASURE: Cost per life year saved. RESULTS: In 1998-9, immediately before the introduction of meningococcal C vaccination, the burden of serogroup C disease was considerable, with an estimated 1137 cases in people aged 0-17 years and at least 72 deaths. The vaccination campaign is estimated to have cost between 126m pound sterling ($180m, 207m) and 241 pound sterling 3m, 395m), depending on the price of the vaccine. Under base case assumptions the cost per life year saved from the vaccination campaign is estimated to be 6259 pound sterling. School based vaccination was more cost effective than general practice based vaccination because of lower delivery costs. Immunisation of infants aged under 1 year was the least cost effective component of the campaign because, although this maximises the life years gained, the three dose schedule required is more expensive than other methods of delivery. Estimates of the cost per life year saved were sensitive to assumptions on the future incidence of disease and the case fatality ratio. CONCLUSIONS: Meningococcal C vaccination is likely to be more cost effective in all age groups when the incidence of disease is high. It is also more cost effective when given to children aged 1-4 (by general practitioners) and to children and young people aged 5-17 years at school than when administered to infants under 12 months of age or young people aged 16-17 years who are not at school.

  • Abstract
  • Author Web Link
  • Cite
• Journal article
  Hails RS, Hernandez-Crespo P, Sait SM, Donnelly CA, Green BM, Cory JSet al., 2002,

  Transmission patterns of natural and recombinant baculoviruses

  , ECOLOGY, Vol: 83, Pages: 906-916, ISSN: 0012-9658
  • Author Web Link
  • Cite
  • Citations: 32

This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.